Ingrid A.V. Wolin

Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies

NLRP3 inflammasome in neuroinflammation and central nervous system diseases

The resilient phenotype elicited by ketamine against inflammatory stressors-induced depressive-like behavior is associated with NLRP3-driven signaling pathway

Physical exercise prevents amyloid β1−40-induced disturbances in NLRP3 inflammasome pathway in the hippocampus of mice